Recombinant human PRG4 (rhPRG4) suppresses breast cancer cell invasion by inhibiting TGFβ-Hyaluronan-CD44 signalling pathway

Anusi Sarkar(University of Calgary), Shirin Bonni(University of Calgary), Tannin A. Schmidt(UConn Health), Lili Deng(Kunming Children's Hospital), Kunal Karve(University of Calgary), Frank R. Jirik(University of Calgary), Ayan Chanda(University of Calgary), Gregory D. Jay(Brown University), Suresh C. Regmi(University of Calgary)
PLoS ONE
July 30, 2019
Cited by 38


Related Papers